You are here

A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors

Last updated on June 17, 2019

FOR MORE INFORMATION
Study Location
Hospital Universitario Fundacion Jimenez Diaz
Madrid, , 28040 Spain
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Neoplasms
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Diagnosis of solid tumor that is advanced/metastatic and resistant to standard
therapy or for whom no standard therapy is available.

- Performance Status of 0 or 1. - Adequate bone marrow, kidney, and liver function.

- Part 2 includes ovarian cancer, target expressing triple negative breast cancer and
non small cell lung cancer patients.

- OVCA pts must have progressed while receiving or within 6mos after completion of at
least 4 cycles of platinum-containing regimen. Prior line of therapy up to 3
regimens.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- OVCA pts excluded with any of the following: non-epithelial, inlcuding malignant
mixed mullerian tumors, prior radiotherapy to pelvis/abdomen, pts with CA-125 only
disease, unresolved bowel obstruction, including sub-occlusive disease, related to
underlying disdease and history of abdominal fistula, GI perforation or
itra-abdominal abscess.

- Brain metastases requiring steroids

- Drug-drug interaction includes advanced metastatic breast cancer, ovarian cancer, or
non small cell lung cancer patients

- Major surgery, radiation therapy, or systemic anti-cancer therapy within 4 weeks of
study treatment start

- Active and clinically significant bacterial, fungal, or viral infection

NCT02222922
Pfizer
Active, not recruiting
A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Neoplasms, Breast Neoplasms
NCT03343054
All Genders
20+
Years
Multiple Sites
Breast Neoplasms, Stomach Neoplasms, Esophagogastric Junction Neoplasm, Non-small-cell Lung Carcinoma
NCT03284723
All Genders
18+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now